510-511 / 1708
NF1-associated OPG:
Treatment strategies and Trial Design
SIGNIFICANT
LOW
WHO TO TREAT
/ OBSERVE
OBSERVE
Vinblastine
Vincristine-
Carboplatin
Treatments /
Strategies
MEK inhibitor
MODERATE
R
R
Visual risk assessment score
Other drugs
?
Primary Outcome PFS and Vision